Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
8.25
-0.63 (-7.09%)
At close: Oct 16, 2026, 4:00 PM EDT
8.29
+0.04 (0.48%)
After-hours: Oct 16, 2026, 7:59 PM EDT
Absci Market Cap
Absci has a market cap or net worth of $1.42 billion as of October 16, 2026. It is the 8,308th most valuable company in the world and the 2,004th biggest in the United States. Its market cap has increased by 89.38% in one year.
Market Cap
1.42B
Enterprise Value
1.22B
1-Year Change
89.38%
Global Rank
Country Rank
#2,004 United States
Category
ChartMarket Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has increased from $423.19M to $1.42B, an increase of 234.56%. That is a compound annual growth rate of 25.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 1.42B | 169.78% |
| Dec 31, 2025 | 524.80M | 74.40% |
| Dec 31, 2024 | 300.92M | -22.91% |
| Dec 29, 2023 | 390.34M | 101.18% |
| Dec 30, 2022 | 194.03M | -74.44% |
| Dec 31, 2021 | 759.25M | 79.41% |
| Jul 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Braveheart Bio | 1.58B |
| Korsana Biosciences | 1.58B |
| Structure Therapeutics | 1.58B |
| Stoke Therapeutics | 1.56B |
| Innoviva | 1.53B |
| Maze Therapeutics | 1.52B |
| uniQure | 1.51B |
| Immunocore Holdings | 1.51B |